Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) Stock Price

BDRXStock

$1.18−96.36%52W

Market Cap$1.21M

P/E—

PEG Ratio—

Div yield—

Beta1.35

BDRX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-92.05%

Price vs S&P 500 (4W)-19.72%

VGM Score4.75

Book Value / Share (Quarterly)$0.00

P/TBV (Annual)0.18x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.00

Price vs S&P 500 (YTD)-101.39%

Net Profit Margin (TTM)-1858.01%

EPS (TTM)$-0.01

10-Day Avg Trading Volume0.15M

EPS Excl Extra (TTM)$-0.01

EPS (Annual)$-0.00

ROI (Annual)-55.68%

Net Profit Margin (5Y Avg)-2372.66%

Cash / Share (Quarterly)$0.00

ROA (Last FY)-35.12%

EBITD / Share (TTM)$-0.00

ROE (5Y Avg)-114.10%

Operating Margin (TTM)-2103.41%

Cash Flow / Share (Annual)$-0.00

P/B Ratio456.65x

P/B Ratio (Quarterly)0.09x

Net Income / Employee (Annual)$-791,749

Net Interest Coverage (TTM)-53.58x

ROA (TTM)-38.69%

EPS Incl Extra (Annual)$-0.00

Current Ratio (Annual)2.03x

Quick Ratio (Quarterly)1.43x

3-Month Avg Trading Volume0.35M

52-Week Price Return-96.36%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$0.00

P/S Ratio (Annual)13669.41x

Asset Turnover (Annual)0.04x

52-Week High$81.03

Operating Margin (5Y Avg)-2597.68%

EPS Excl Extra (Annual)$-0.00

CapEx CAGR (5Y)27.02%

26-Week Price Return-80.80%

Quick Ratio (Annual)1.43x

13-Week Price Return-62.96%

Total Debt / Equity (Annual)0.01x

Current Ratio (Quarterly)2.03x

Enterprise Value$7.09B

Asset Turnover (TTM)0.04x

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-1964.57%

Cash / Share (Annual)$0.00

3-Month Return Std Dev80.43%

Net Income / Employee (TTM)$-791,749

ROE (Last FY)-55.98%

EPS Basic Excl Extra (Annual)$-0.00

Receivables Turnover (TTM)0.00x

Total Debt / Equity (Quarterly)0.01x

EPS Incl Extra (TTM)$-0.01

Receivables Turnover (Annual)0.00x

ROI (TTM)-54.56%

P/S Ratio (TTM)13669.41x

Pretax Margin (5Y Avg)-2539.69%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$0.00

Price vs S&P 500 (52W)-114.67%

Year-to-Date Return-89.43%

5-Day Price Return-13.67%

EPS Normalized (Annual)$-0.00

ROA (5Y Avg)-64.38%

Net Profit Margin (Annual)-1858.01%

Month-to-Date Return-9.09%

EBITD / Share (Annual)$-0.00

Operating Margin (Annual)-2103.41%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-101.51%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.01

P/TBV (Quarterly)0.18x

P/B Ratio (Annual)0.09x

Pretax Margin (TTM)-1964.57%

Book Value / Share (Annual)$0.00

Price vs S&P 500 (13W)-65.76%

Beta1.35x

Revenue / Share (TTM)$0.00

ROE (TTM)-55.90%

52-Week Low$1.39

mGradeF

vgmGradeF

BDRX Analyst Recommendations

Dec 2025

Jan 2026

Feb 2026

Mar 2026

4.29

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
BDRXBiodexa Pharmaceuticals plc American Depositary Shs	—	—	F	$1.18
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Biodexa Pharmaceuticals plc American Depositary Shs

Biodexa Pharmaceuticals develops therapies targeting diseases with significant unmet medical needs. The clinical-stage company's pipeline spans familial adenomatous polyposis, non-muscle invasive bladder cancer, type 1 diabetes, and orphan brain cancers.